FDA backs new $82M mR­NA man­u­fac­tur­ing cen­ter at MIT

The Mass­a­chu­setts In­sti­tute of Tech­nol­o­gy will be aim­ing to de­sign and in­stall a new con­tin­u­ous mR­NA man­u­fac­tur­ing plat­form, with help from the fed­er­al gov­ern­ment.

Ac­cord­ing to MIT on Thurs­day, the project, backed by $82 mil­lion from the FDA’s Cen­ter for Bi­o­log­ics Eval­u­a­tion and Re­search over three years, will aim to ad­vance the field of mR­NA ther­a­peu­tics by pro­vid­ing a con­tin­u­ous man­u­fac­tur­ing tem­plate for oth­er com­pa­nies to fol­low, while fa­cil­i­tat­ing col­lab­o­ra­tion through­out the bio­phar­ma in­dus­try.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER